Persistence With Mirabegron Versus Tolterodine in Patients With Overactive Bladder
In a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Read More